Robert F. Kennedy Jr. continues to serve as HHS Secretary with sustained White House alignment on Make America Healthy Again priorities, including vaccine policy revisions, food safety reforms, and department reorganization through political appointees. As of early September 2026, he remains actively engaged in leadership decisions, recent FDA announcements, congressional testimony, and responses to public health issues such as measles outbreaks, with no official statements or credible reporting indicating resignation or removal before October 31. Trader consensus reflected in the 93.5% implied probability for “No” stems from this ongoing presidential backing and the absence of procedural or political triggers that would force an exit, though late-session developments or shifting administration dynamics could still alter the timeline.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedAn announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Market Opened: Sep 3, 2026, 9:28 AM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...Robert F. Kennedy Jr. continues to serve as HHS Secretary with sustained White House alignment on Make America Healthy Again priorities, including vaccine policy revisions, food safety reforms, and department reorganization through political appointees. As of early September 2026, he remains actively engaged in leadership decisions, recent FDA announcements, congressional testimony, and responses to public health issues such as measles outbreaks, with no official statements or credible reporting indicating resignation or removal before October 31. Trader consensus reflected in the 93.5% implied probability for “No” stems from this ongoing presidential backing and the absence of procedural or political triggers that would force an exit, though late-session developments or shifting administration dynamics could still alter the timeline.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated

Beware of external links.
Beware of external links.
Frequently Asked Questions